News
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative ...
Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...
I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still ...
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results